Gaël Champier
Amministratore Delegato presso B Cell Design SAS
Profilo
Gaël Champier founded B Cell Design SAS, where they worked as Chief Executive Officer.
Dr. Champier also currently works at ArkAb SAS, as Chief Executive Officer & Director from 2018.
Dr. Champier received their graduate degree from Université de Limoges.
Posizioni attive di Gaël Champier
| Società | Posizione | Inizio |
|---|---|---|
B Cell Design SAS
 B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Amministratore Delegato | - |
ArkAb SAS
 ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | Amministratore Delegato | 13/01/2018 |
Formazione di Gaël Champier
| Université de Limoges | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
ArkAb SAS
ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | Health Technology |
B Cell Design SAS
B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Commercial Services |
- Borsa valori
- Insiders
- Gaël Champier
